Filing Details
- Accession Number:
- 0001209191-15-071497
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-18 20:27:15
- Reporting Period:
- 2015-09-16
- Filing Date:
- 2015-09-18
- Accepted Time:
- 2015-09-18 20:27:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1294133 | Inogen Inc | INGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1596086 | Byron Myers | 326 Bollay Drive Goleta CA 93117 | Vice President, Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-16 | 400 | $0.60 | 36,732 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-09-16 | 1,300 | $0.60 | 38,032 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-16 | 400 | $55.00 | 37,632 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-16 | 1,300 | $55.00 | 36,332 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-09-16 | 400 | $0.00 | 400 | $0.60 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-09-16 | 1,300 | $0.00 | 1,300 | $0.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-02-10 | No | 4 | M | Direct | |
30,831 | 2020-02-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2015.
- Subject to the reporting person's continued service, sixty percent (60%) of the shares subject to the option vested and became exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012.